News


Jinlangbo Pharmaceutical shines at Thailand's VIV Asia, deepening international cooperation and jointly pursuing new industry development!


March 13, 2025, Bangkok, Thailand - King-New Group's Jinlangbo Pharmaceutical, a globally leading enterprise in the entire hydroxyvitamin D3 industry chain, made a stunning appearance at the VIV Asia exhibition in Bangkok, Thailand. Chen Yulong, the company's General Manager, personally led a team, including the foreign trade sales and technical support teams, to join old and new customers from around the world in celebrating this significant event and discussing the future development of the livestock industry.

As the largest and most influential livestock industry event in Asia, VIV Asia brings together top enterprises and industry elites from around the world. Jinlangbo Pharmaceutical's participation in this exhibition not only showcased the company's latest products and technological achievements, but also facilitated in-depth exchanges with numerous new and old customers, further consolidating cooperative relationships and actively exploring new market opportunities.

During the exhibition, Mr. Chen and his team actively participated in industry forums and technical seminars, sharing Jinlangbo Pharmaceutical's innovative concepts and practical experiences in the field of animal nutrition with global peers, and received widespread recognition and praise. Mr. Chen stated that Jinlangbo Pharmaceutical has always been customer-oriented, continuously increasing R&D investment, and committed to providing higher-quality products and services to global customers.

This trip to VIV Asia marks an important step for Jinlangbo Pharmaceutical in deepening its internationalization strategy. Moving forward, the company will continue to uphold the principles of "innovation, quality, and service," and work hand in hand with global partners to contribute to the healthy development of the livestock industry.